These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7163480)

  • 41. Redox processes in radiation biology and cancer.
    Greenstock CL
    Radiat Res; 1981 May; 86(2):196-211. PubMed ID: 7195057
    [No Abstract]   [Full Text] [Related]  

  • 42. [Growth kinetics and functional morphology of M-1 sarcoma in rats before and after gamma-irradiation].
    Iuzhakov VV; Khavinson VKh; Kvetnoĭ IM; Fomina NK; Kuznetsova MN
    Vopr Onkol; 2001; 47(3):328-34. PubMed ID: 11544833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical studies of the novel vascular disrupting agent MN-029.
    Shi W; Siemann DW
    Anticancer Res; 2005; 25(6B):3899-904. PubMed ID: 16309177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of different schedules of dose fractionation on the oxygenation status of a transplantable mouse sarcoma.
    Kallman RF; Jardine LJ; Johnson CW
    J Natl Cancer Inst; 1970 Feb; 44(2):369-77. PubMed ID: 11515079
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis, pulse radiolysis, and in vitro radioprotection studies of melatoninolipoamide, a novel conjugate of melatonin and alpha-lipoic acid.
    Venkatachalam SR; Salaskar A; Chattopadhyay A; Barik A; Mishra B; Gangabhagirathi R; Priyadarsini KI
    Bioorg Med Chem; 2006 Sep; 14(18):6414-9. PubMed ID: 16766192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidation of human high-density lipoproteins by .OH and .OH/O(.-)2 free radicals.
    Bonnefont-Rousselot D; Khalil A; Delattre J; Jore D; Gardès-Albert M
    Radiat Res; 1997 Jun; 147(6):721-8. PubMed ID: 9189171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experimental studies on the recovery from the injury of radiation--especially, about the growth rate of irradiated tumor (Takizawa's sarcoma) after transplantation].
    Katsuta S
    Zasshi Tokyo Ika Daigaku; 1970 May; 28(3):389-419. PubMed ID: 5535751
    [No Abstract]   [Full Text] [Related]  

  • 49. Reactivity of nitro-thiophene derivatives with electron and oxygen radicals studied by pulse radiolysis and polarographic techniques.
    Breccia A; Busi F; Gattavecchia E; Tamba M
    Radiat Environ Biophys; 1990; 29(3):153-60. PubMed ID: 2396005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitomycin C radical cation studied by pulse radiolysis.
    Getoff N
    In Vivo; 2003; 17(2):173-6. PubMed ID: 12792981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical, pulse radiolysis and density functional studies of a new, labile 5,6-indolequinone and its semiquinone.
    Pezzella A; Crescenzi O; Natangelo A; Panzella L; Napolitano A; Navaratnam S; Edge R; Land EJ; Barone V; d'Ischia M
    J Org Chem; 2007 Mar; 72(5):1595-603. PubMed ID: 17266371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The optimization of a plan for the photodynamic therapy of sarcoma M1 using photosens].
    Lagoda TS; Kaplan MA; Krivosheev IaV; Zhavoronkov LP; Bokova MB
    Vopr Onkol; 2000; 46(3):327-31. PubMed ID: 10976280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mechanism of action of the radiosensitizing substance synkavit: ESR studies.
    Lohmann W
    Strahlentherapie; 1972 Sep; 144(3):319-23. PubMed ID: 4343598
    [No Abstract]   [Full Text] [Related]  

  • 54. Marked difference in cytochrome c oxidation mediated by HO(*) and/or O(2)(*-) free radicals in vitro.
    Thariat J; Collin F; Marchetti C; Ahmed-Adrar NS; Vitrac H; Jore D; Gardes-Albert M
    Biochimie; 2008 Oct; 90(10):1442-51. PubMed ID: 18555026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
    Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
    Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Choice of dose distribution during modelling of non-uniform radiation on experimental animals].
    Aliev BM; Galina LS
    Med Radiol (Mosk); 1972 Feb; 17(2):61-5. PubMed ID: 5036253
    [No Abstract]   [Full Text] [Related]  

  • 57. [Apoptosis of mouse MS-2 fibrosarcoma cells induced by photodynamic therapy with LDL-administered zinc-phthalocyanine].
    Zhou C; Chi S; Deng J; Liang J; Biolo R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Feb; 17(1):25-9. PubMed ID: 7781124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the effectiveness of NF-167 and metronidazole as hypoxic cell sensitizers of KHT tumor cells in vitro.
    Thomson JE; Rauth AM
    Radiat Res; 1974 Dec; 60(3):489-500. PubMed ID: 10881726
    [No Abstract]   [Full Text] [Related]  

  • 59. Chloroquine: nonselective inhibition of recovery from radiation injury in tumors and normal tissues.
    Pazmiño NH; Yuhas JM
    Radiat Res; 1974 Oct; 60(1):54-61. PubMed ID: 10881699
    [No Abstract]   [Full Text] [Related]  

  • 60. The potential for radiation sensitizers and possible strategy for use.
    Whitmore GF
    Laryngoscope; 1975 Jul; 85(7):1145-54. PubMed ID: 1097849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.